| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1007/S12350-017-0963-3 |
| P698 | PubMed publication ID | 28752313 |
| P50 | author | Mouaz Al-Mallah | Q37828820 |
| Daniel S Berman | Q89697826 | ||
| Ron Blankstein | Q90238982 | ||
| Leslee J Shaw | Q94570815 | ||
| Marcelo F Di Carli | Q114294057 | ||
| Rory Hachamovitch | Q114406980 | ||
| P2093 | author name string | Joe X Xie | |
| Lawrence M Phillips | |||
| Todd D Miller | |||
| David E Winchester | |||
| P2860 | cites work | Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging | Q26827495 |
| A Randomized Trial of Intensive versus Standard Blood-Pressure Control | Q27231406 | ||
| Fractional flow reserve versus angiography for guiding percutaneous coronary intervention | Q28306779 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q29620108 | ||
| Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascu | Q30411237 | ||
| A randomized trial of therapies for type 2 diabetes and coronary artery disease | Q33827504 | ||
| Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials | Q34389294 | ||
| Optimal medical therapy with or without PCI for stable coronary disease | Q34612445 | ||
| Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents | Q35783487 | ||
| Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging | Q36656796 | ||
| Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction | Q37127474 | ||
| Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. | Q37637815 | ||
| Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes | Q39199676 | ||
| Status of and trends in nuclear medicine in the United States | Q39673878 | ||
| Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography | Q40585925 | ||
| Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging | Q40850909 | ||
| 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management | Q40975493 | ||
| Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain | Q41446749 | ||
| Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia | Q45253615 | ||
| Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. | Q45938236 | ||
| Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. | Q46008570 | ||
| Adenosine stress cardiac magnetic resonance imaging for the assessment of ischemic heart disease | Q46382627 | ||
| Effect of PCI on quality of life in patients with stable coronary disease | Q46429326 | ||
| ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for | Q48532193 | ||
| Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. | Q51037352 | ||
| Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. | Q51051973 | ||
| 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart | Q52956605 | ||
| Stress-induced wall motion abnormalities with low-dose dobutamine infusion indicate the presence of severe disease and vulnerable myocardium. | Q54600220 | ||
| Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease | Q61651378 | ||
| Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion | Q66912822 | ||
| Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris | Q69496536 | ||
| Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease | Q70018282 | ||
| Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography | Q71977968 | ||
| Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging | Q73205398 | ||
| Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction | Q74288420 | ||
| Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease | Q74319206 | ||
| The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter S | Q74611586 | ||
| The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group | Q77407529 | ||
| Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease | Q77437412 | ||
| Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy | Q80681924 | ||
| Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention | Q84761062 | ||
| Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009 | Q86323672 | ||
| P433 | issue | 5 | |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 1610-1618 | |
| P577 | publication date | 2017-07-27 | |
| P1433 | published in | Journal of Nuclear Cardiology | Q609415 |
| P1476 | title | The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer? | |
| P478 | volume | 24 |
Search more.